Jiang Xiaomeng: A Centennial Enterprise with Craftsman Spirit
Release time:
2020-07-31
Editor's Note: days ago, the United Front Work Department of Jinhua Municipal Committee, the Municipal Federation of Industry and Commerce and other units jointly launched a large-scale publicity campaign on "2016 Letter to Good Wu Merchants". 10# June 18 , Jinhua media reporters walked into the peak and made a collective interview with Chairman Jiang Xiaomeng. 10# October 21 , the front page of Jinhua Daily published the article "Jiang Xiaomeng: Strive for a Century of Enterprise with Craftsman Spirit" written by its reporter Zhang Shuai. This newspaper is reproduced.
58 , Chairman Jiang Xiaomeng's face is filled with passion and confidence.
58 years, the peak has experienced ups and downs. Every time it encounters a major turning point, generations of "peak people" have opened a new chapter with tireless efforts and simple wisdom.
11.03 .6 billion yuan, up 4.15% over the same period of last year; Net profit attributable to owners of the parent company reached 1.03 billion yuan, up 12.9 year on year. These data in the current weak domestic economic development, has become more prominent.
58 years, and are also the models of our "wushang" group to stick to industry, operate in good faith and serve the country by industry.
58 years ago, bearing in mind the history of the peak, can be seen at a glance by many old Jin Chinese. This is the original site of the Wisdom Temple in the north of Jinhua City. The place was small and desolate. The first group of pioneers built the first cement factory in Jinhua with their hands and blood.
20 years old, he walked into the gate of the cement factory and is now leading thousands of people to fight the business world. Jiang Xiaomeng said that this is the common growth and achievement of individuals and enterprises. 1993
28 , unusual for Jianfeng Group. On this day, Jianfeng stock started trading on the Shanghai Stock Exchange and became the country's first listed company in the cement industry, which laid the foundation for the standardized management and further development of Jianfeng Group. to 2006
2007 , the cement market competition is extremely fierce, coupled with the state's policy restrictions on the closure of mechanical vertical kilns, many cement plants have lost their competitiveness. Spikes are also facing harsh realities, and benefits are plummeting. At this key node, Jianfeng cooperated with central enterprises in a timely manner to transfer the equity of cement enterprise 65% in Zhejiang Province, set up Southern Cement, became one of the sponsors of Southern Cement, and invested limited funds in the central and western regions with more advantages in market prospects, resources and supply. After the most difficult period from 2006 to
, Jianfeng promptly established the development policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development", and became an industrial pattern with cement and medicine as the two main businesses, bonded logistics as the supplement, and multiple investments in concentric related industries as the supplement, which further clarified the industrial positioning of the group, be a niche in the cement market, a leader in the pharmaceutical industry segment, and a leader in health product innovation. Jiang Xiaomeng said that these decisions are strategic choices made in combination with the actual situation of the peak and the development trend, and are the self-adjustment of the peak group on the road of development. Only when the positioning is accurate and the goal is clear can an enterprise have the driving force for sustainable development.
Looking forward to the future, driven by innovation in medicine and health, the industry is booming
. Besides complementing cement and having a broad market, Jiang Xiaomeng hopes to stimulate the vitality of the peak through medicine and health.
During the peak years of
, Jiang Xiaomeng knew very well that innovation and development are the best catalysts for enterprises to maintain vitality. To be brave, transformation and upgrading are the best driving forces. The medical and health industry is also one of the most obvious industries driven by scientific and technological innovation. Jianfeng Pharmaceutical has always paid attention to the innovative research and development of pharmaceutical products. It has two professional research institutions and a provincial new drug research and development center. At the same time, it has
academician expert workstations and 3 postdoctoral mobile stations in the field of plant extracts and chemical pharmaceuticals respectively, and has obtained more than 20 national invention patents . This has laid a solid foundation for the innovation of peak pharmaceutical products. Many products of Jianfeng Pharmaceutical have been listed as national high-tech industrialization demonstration project, national key new product plan project and national torch plan project, and have been rated as national high-tech enterprises for 10 years in a row. In addition, with the deepening of the management of pharmaceutical commercial circulation order, the peak will effectively integrate the existing internal circulation enterprises in the field of circulation, and constantly improve the profitability and business model with innovative thinking, so as to make the pharmaceutical circulation enterprises more standardized, more orderly and stronger, and further enhance their competitiveness. Jianfeng Health Technology Co., Ltd. is another major layout of Jianfeng Group in the field of health in recent years. Entering the company's laboratory, high-tech experimental equipment can be seen everywhere. In front of a piece of equipment, Yu Hongjian, general manager of the Health Technology Company, told reporters that this is the first production equipment used in ginkgo extract in China. The entire production process is operated and monitored in real time by the computer system in the central control room to minimize Human errors and risks ensure stable and safe product quality. In the central control room, the reporter also saw two staff members staring at the large computer screen all the time, paying attention to the changes in the monitoring values on the screen.
In the Peak Health Experience Hall, Jiang Xiaomeng introduced that the big health industry is a very broad concept, including health care products, health care for the aged, health care, etc. With the improvement of people's living conditions, people's demand will be more and more big. The human demand for health, health care and longevity is an irreversible trend and trend. The positioning of the peak for the big health industry is: natural raw materials, ancient and modern use, changing tradition into fashion, and being a leader in health product innovation. Around this concept, Spike has done a lot of work in innovative decoction pieces and has obtained a number of patents, for example, many people know that eating Gastrodia elata is good, but the texture of Gastrodia elata is hard, how to eat it? Spike Health makes Gastrodia elata slices that dehydrate and freeze-dry slices of fresh Gastrodia elata, which is as simple and convenient as eating potato chips. There are also freeze-dried ultra-fine powder of noto-ginseng, freeze-dried Dendrobium, heart-shaped Astragalus tablets and so on.
listed
years, Jianfeng Group's total assets have increased from 1.38 .2 billion yuan at the beginning of listing to 35.78 .4 billion yuan now, and its net assets have increased from less than 1 .6 billion yuan to 22.01 .8 billion yuan, increasing nearly 26 times and 22 times respectively. operates in good faith, sticks to industry, and does not forget social responsibility
In the Jianfeng History Showroom, photos with historical accumulation make people feel that Jianfeng Group is working hard and at the same time, they also see Jianfeng's active social responsibility. Since the listing of
, the peak tax payment and social security payment have exceeded
.3 billion yuan, which has been a major taxpayer of enterprises in Jinhua for many years. Jianfeng Group, Jianfeng Pharmaceutical, Jianfeng Cement and other holding companies were rated as Zhejiang Province 3A -class contract-abiding and trustworthy units, integrity management enterprises. Jianfeng Group has just won the silver award of "Zhejiang Industry Award" in 2016 this year, and is the second batch of "three" cultivation pilot enterprises in Zhejiang Province. Jianfeng Group has also carried out fruitful work in enterprise pairing, thousand enterprise pairing, and employee labor security. It has been rated as an advanced ideological and political work unit in Zhejiang Province and Jinhua City for many years. started from
April with a donation of of 20 .56 million yuan to build "Zhejiang Jianfeng Hope Primary School" (the first Hope Primary School on the "Roof of the World" aided by an enterprise) in Nagqu District of Tibet Autonomous Region. Jianfeng Group's "Hope" road lasted for 21 years. In the meantime, 8 Hope Primary School, which was built with high-end donations, has sprung up. Its donation areas cover Tibet, Gansu, Yunnan and our Jinhua region.
.5 billion yuan in environmental protection technological transformation funds exceeding . Because ecological development has been implanted into corporate culture, many important activities can always see the figure of the peak, such as Jinhua five water co-governance, Wenchuan earthquake relief, Jinhua Red Cross donation AED automatic defibrillator and so on.
58 years, in addition to the upbringing of Jinhua, is also because the peak development has four cornerstones: a strong corporate culture, a development path suitable for itself, and an endogenous expansion desire that matches its own strength, there is a management team that highly identifies with the culture of spikes. "Our mission is to be a century-old peak, and generations of peak people will dream of the future with the spirit of craftsmen." ("Jinhua Daily" reporter Zhang Shuai)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31